Home
overview

The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.

The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.
 

Developing on last years success, this event assembles an international audience to include regulatory, device design, packaging and  formulation professionals.  The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.  
 

This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following: 

- Life cycle management for developing devices that are both user friendly and revenue effective
- Device design considerations
- Long acting injectables and bringing these therapeutics to market with case studies
- Connected devices, GDPR and cyber security programs
-Developments in primary packaging
-Growth in transdermal delivery and subcutaneous infusion devices
-Digital health partnerships
-Large volume patch pump innovation examples

 


 

Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:
• Autoinjectors
• Wearables
• Device Engineering
• Human Factors
• CMC
• Injectables
• Sterile Manufacturing
• Packaging
• Regulatory Affairs

 

AbbVie; Aptar France SAS; AstraZeneca; Barts Health NHS Trust; Cambridge Consultants Ltd; Cambridge Design Partnership; Cantab Innovations; Credence MedSystems; Crux Product Design, Ltd; Enable Injections; Enesi Pharma Ltd; F. Hoffmann-La Roche Ltd; Fresenius Kabi Deutschland GmbH; GSK; Human Factors Centre Ltd; IPSEN; Janssen; KCL; LEO Pharma A/S; Mallinckrodt Pharmaceuticals; MedinCell; MHRA; New Injection Systems Ltd; Novaliq GmbH; Novartis Pharma GmbH; Owen Mumford; Pfizer; Phillips - Medisize; Phillips-Medisize; Roche Pharmaceuticals; Sanofi-Aventis; Sanofi-Aventis R&D; University College London; UroPharma Limited; W.L. Gore & Associates, Inc.; Weidmann Medical Technology Ag; Worrell;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Joel Richard

Joel Richard, Head of Technical & Pharmaceutical Operations, MedinCell
View Bio

9:10 Overcoming the challenges in development of injectable protein formulations

Vasco Filipe

Vasco Filipe, Senior research scientist - Formulation Development, Sanofi
View Bio

  • High viscosity that exceeds the capabilities of current manufacturing practices or available parenteral delivery methods
  • High concentration leading to stability and aggregation concerns and the associated material required for a robust development strategy
  • High volume biologic challenges and strategies to overcome them
  • Viscosity reducing excipients
  • 10:30 Morning Coffee

    11:00 Formulation development for long acting injectables

    Joel Richard

    Joel Richard, Head of Technical & Pharmaceutical Operations, MedinCell
    View Bio

  • Considerations for long-acting formulation development
  • Overcoming challenges
  • A game-changing delivery system for long acting injectables
  • Future prospects
     
  • 11:40 Development of Visisure, a novel low volume high accuracy syringe for delivery of Lucentis to neonates

    Stephen Paboojian

    Stephen Paboojian, Senior New Technology Project Leader II, Novartis Pharma AG
    View Bio

  •  Background on Retinopathy of Prematurity and impact to patients
  •  Drivers and constraints for development: user, business, and regulatory
  • Technical challenges overcome: device, packaging, manufacturing, and HFE
  •  Final product configuration and supply chain
  • 12:20 Networking Lunch

    13:20 Ethical principleas in human factors studies and developing a code of conduct

  • Overview of current HF study trends
  • Ethical considerations of HF Studies
  • Proposed considerations for ethical code of conduct
  • Miranda Newbery

    Miranda Newbery, Human Factors Consultant, Inspired Usability
    View Bio

    Louisa Harvey

    Louisa Harvey, Director, Harvey Medical Consulting Ltd
    View Bio

    14:00 Partners in evolution: Challenges and changes in parental drug delivery

    John Burke

    John Burke, Senior Consultant, Team Medical Devices
    View Bio

  •  A summary of key trends and changes in the device landscape
  • Highlight potential pitfalls to avoid
  • The device as an enabler rather than a barrier to market success
  • 15:20 Afternoon Tea

    15:50 A convergent approach to the regulatory framework for combination products

    Blake Green

    Blake Green, Senior Manager Regulatory Affairs, Amgen
    View Bio

  •  An overview of current approaches for combination product regulations
  • Avoiding divergence, proposed convergent approach to ensure compliance and improve practice
  •  Potential implications on the industry
  • 16:30 An industrial perspective on ICH Q12 and EU MDR

    Bjorg Kaae Hunter

    Bjorg Kaae Hunter, Device Engineering Manager, GlaxoSmithKline
    View Bio

     

     

    ·         Changes in the global regulatory environment and processes for in cooperating emerging trends into internal regulatory strategies
    ·          Control strategies and compliance with quality systems for a medical delivery device
    ·          Compliance with quality systems and medical devices
    ·          Examples of how to direct a team for late stage parental development.

    17:10 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Sigrid Van Dyck

    Sigrid Van Dyck, Senior Director Technical Operations, Janssen Supply Chain, Johnson & Johnson
    View Bio

    9:10 Driving innovation in the drug delivery market

    Mayur Patel

    Mayur Patel, Leading innovative medical and combination product development, PA Consulting
    View Bio

  • Future of the drug delivery market - an overview 
  • How we can improve patient adherence with connectivity and innovation
  • 9:50 Partnering for drug delivery innovation progress and AstraZeneca’s strategic considerations in successful outsourcing

    Terry Reed

    Terry Reed, Director Business Development, AstraZeneca
    View Bio

  • AstraZeneca’s approach to seeking and engendering innovation in its drug delivery organisation
  • Structuring deals to leverage the expertise of outsourcing partners – key considerations for commercial success
  • An overview of the search for key technologies and solutions to support the portfolio of activities and developments
  • Learning points from a recent case
  • 10:30 Morning Coffee

    11:00 Development of electronic auto-injectors - from concept to manufacture

    Quentin Le Masne

    Quentin Le Masne, Head of Engineering team - Electro-Medical, Drug Delivery Devices, Merck
    View Bio

  • Overview of the development process – the do’s and don’ts
  • The challenges and learnings of electronic and connected drug delivery devices
  • User experience and patient-centric design: what do patients really want from electronic auto-injectors?
     
  • 11:40 Digital rapid prototyping-using the latest prototyping methods to unlock the value of digital propositions faster

    Tom Lawrie-Fussey

    Tom Lawrie-Fussey, Head of Digital Health, Cambridge Design Partnership
    View Bio

  • Case studies that navigate through the risks and rewards of deploying digital into healthcare products and services
  • Learn how we uncover surprising insights in human factors and product development
  •  We’ll share a number of toolkits and approaches we use which help us to better quantify user experiences; highlighting where the value in digital can be captured and monetised.
  •  

    12:20 Networking Lunch

    13:20 The route to patient centric drug delivery

    Olaf Lebau

    Olaf Lebau, Design Engineer for Medical Device and Combination products, Boehringer Ingelheim GmbH
    View Bio

     

    • Patient considerations and pharmaceutical connectivity limitations
    • Cost vs. Adherence, where does the benefits lie?
    • Contamination control where disposables are not an option – patient safety focus
    • Realistic patient experience approach

    15:10 Afternoon Tea

    15:40 Manufacturing, filling and quality control

    Sigrid Van Dyck

    Sigrid Van Dyck, Senior Director Technical Operations, Janssen Supply Chain, Johnson & Johnson
    View Bio

  • Device Design - long acting injectables and biologics
  • Design for manufacturing - filling, automated inspection and packaging
  • Quality assurance considerations
  • 16:20 Manufacturing inspection trends

    Paul Kinsey

    Paul Kinsey, QA Manager, GSK
    View Bio

    17:00 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Joel Richard

    Joel Richard

    Head of Technical & Pharmaceutical Operations, MedinCell
    Quentin Le Masne

    Quentin Le Masne

    Head of Engineering team - Electro-Medical, Drug Delivery Devices, Merck
    Stephen Paboojian

    Stephen Paboojian

    Senior New Technology Project Leader II, Novartis Pharma AG
    Vasco Filipe

    Vasco Filipe

    Senior research scientist - Formulation Development, Sanofi

    Adeline Meilhoc

    VP Sales & Marketing, Eveon
    Adeline Meilhoc

    Adeline Meilhoc is an expert in drug clinical development and in digital environment around medical devices. She is specialist of innovation product setup and deployment dedicated to patients and health care professionals. In the last 15 years, she proposes commercial and operational partnership solutions to pharma and biotech industry. She accompanies them in their efforts to enhance patient's treatment adherence in analyzing health real-world data. Clinical psychologist, specialist in Health & Society, she is focusing now on international commercial deals for drug preparation and administration, in proposing a bridge between R&D and Market access.

    Bjorg Kaae Hunter

    Device Engineering Manager, GlaxoSmithKline
    Bjorg Kaae Hunter

    Bjorg Hunter holds a BSc in Design and Innovation Engineering from Technical University of Denmark and an MSc in Biomedical Engineering from Aarhus University, Denmark. Bjorg has been with GSK since graduating and has held different roles within the Device Engineering Group. In 2015 Bjorg moved into the late stage parenterals area as device lead for key GSK parenteral devices, working closely with internal GSK project teams and external partners. She progressed into leading a device management team in January 2017, where she has accountability of project management and regulatory compliance for parenteral devices. Bjorg has presented at several key pharmaceutical conferences on pharmaceutical topics, specifically in relation to combination product and regulatory guidance.

    Blake Green

    Senior Manager Regulatory Affairs, Amgen
    Blake Green

    Blake Green is a Regulatory Affairs Senior Manager with Amgen’s Global Medical Devices Regulatory team. Based in Cambridge UK. Blake is a Devices Regulatory lead for medicinal product/medical device combination products and co-packaged medical devices in the biopharmaceutical sector. Prior to joining Amgen, Blake had significant international experience securing multi-national market clearance for manufacturers of medical devices, medical device/medicinal product combinations, medical software, personal protective equipment, and biocides, located throughout the United States of America, European Union, North Africa, Middle East, Far East, Turkey, Israel, Australia, Canada, and Peoples Republic of China.

    Edward Sims

    Senior Designer & Associate , Crux Product Design, Ltd
    Edward Sims

    Joel Richard

    Head of Technical & Pharmaceutical Operations, MedinCell
    Joel Richard

    Dr Richard is presently leading the Technical and Pharmaceutical Development activities for the Medincell Company, Lead Candidate Selection to all Clinical Development Phases.
     

    Dr Joël Richard graduated from Ecole Normale Supérieure (Cachan, France) and got his PhD in Materials Science/Colloids & Interface Science from University of Paris VI. Dr Richard has 30 years of experience in chemistry and biopharmaceutical R&D, including several global senior leadership positions in various Biotech and Pharma companies, such as Medincell, Ipsen, Merck Serono, Serono and Ethypharm. He also had an entrepreneurial experience, co-funding Mainelab (France) with Pr Jean-Pierre Benoit, a drug delivery company specialized in developing solvent-free processes for protein delivery systems. Dr Richard has focused his research activity on new formulations and drug delivery systems (such as microspheres, nanoparticles, self-assembling gel systems, chemically-modified proteins, supercritical fluid technology . . .), especially for injectable protein and peptide formulations. Dr Richard has published 68 peer-reviewed scientific papers, 8 book chapters and 2 editorials in various fields (colloids and interfaces, drug delivery, supercritical fluids, protein formulations, sustained-release formulations…). He is the author of more than 140 international communications and 55 patent families.

     

    John Burke

    Senior Consultant, Team Medical Devices
    John Burke

    John specializes in the design and project management of medical devices with a particular focus on the development of parenteral drug delivery devices. A designer by training with a strong grounding in medical design and regulatory focused human factors, he regularly attends user studies in both Europe and the US.
     

    On projects he seeks to balance technical, user and commercial requirements to produce simple elegant solutions. Over the years, John has worked on a range of parenteral device developments with leading pharma companies in both Europe and the US and has a good knowledge and understanding of the market, current devices and trends.
     

    John brings experience of both consumer and medical product development, having worked on a diverse range of products, including drug delivery devices, wound management, diagnostics platforms and blood glucose monitoring.
     

    Louisa Harvey

    Director, Harvey Medical Consulting Ltd
    Louisa Harvey

    Louisa is an experienced medical device human factors consultant. Louisa has an MSc in Industrial Pharmaceutical Science and began her career working in clinical trials. Louisa has a broad-range of experience working in both the pharmaceutical and medical device industries in technical and commercial roles. Having spent a number of years working with most of the Cambridge-based medical consultancies, she has inputted into the design of many different products from auto-injectors through to large surgical systems.

    Louisa specializes in conducting studies in vulnerable patient groups always ensuring her studies are designed with ethics in mind from the outset.
     

    Mayur Patel

    Leading innovative medical and combination product development, PA Consulting
    Mayur Patel

    Mayur Patel is an experienced Project Manager and Clinical Scientist [Health and Care Professions Council UK registered CS18187 – a regulated professional qualification required to advise safety and effectiveness of medical devices/ physiological measurement techniques in the NHS]. He has a strong track record in leading the development of innovative devices and techniques in medical and drug-device combination device sectors. Mayur holds a Masters Degree in Engineering and Physical Science in Medicine from Imperial College London. He lectures King’s College London postgraduate students and trainee clinical scientists on a range of medical device and healthcare management subjects.

    Miranda Newbery

    Human Factors Consultant, Inspired Usability
    Miranda Newbery

    Miranda is a creative design and usability consultant specialising in medical device developments. In 2016 she founded Inspired Usability, a medical device human factors consultancy. She works on early design research through to human factors validation on a range of medical device and combination products. Miranda originally studied Engineering (Cambridge University) and Industrial Design (Royal College of Art) and is a chartered ergonomist with the CIEHF. In 2018 Miranda and Louisa Harvey started the Medical Human Factors Network UK, with the aim of brining together like-minded professionals and raisi

    Olaf Lebau

    Design Engineer for Medical Device and Combination products, Boehringer Ingelheim GmbH
    Olaf Lebau

    Design Engineer for Medical Device and Combination Products, Boehringer Ingelheim

    Olaf is an applied physicist by training with a broad knowledge in interdisciplinary fields like nanotechnology and biomimetics.
    Over the years, he has worked on extracorporeal circuits, in vitro diagnostic, predictive algorithms and complex drug delivery systems.

    After joining Boehringer Ingelheim, he is currently working on combination products for new pharmaceuticals as well as innovation projects for smart and connected drug delivery devices.
     

    Paul Kinsey

    QA Manager, GSK
    Paul Kinsey

    Paul is currently the platform lead for visual inspection and leak detection in the biopharm & steriles manufacturing science group, GSK pharma division. He has almost 30 years in pharma secondary manufacturing, including roles in QA, QC, technical, validation & production operations. For the last 13 years Paul’s responsibilities have included visual inspection and leak detection practice and policy for a broad range of sterile finished product presentations across the pharma and vaccines divisions covering Europe, the US, Japan and emerging markets.

    Quentin Le Masne

    Head of Engineering team - Electro-Medical, Drug Delivery Devices, Merck
    Quentin Le Masne

    Quentin Le Masne holds a Master’s Degree in Engineering for Ecole Centrale de Paris and a PhD in Physics from Paris University. He has worked in numerous positions in the field of medical devices, from In-Vitro Diagnostic to Drug Delivery Devices, restlessly bringing highly innovative ideas from lab to market. His work focuses on the management of engineering teams with diverse expertise like electronic, mechanics, human factors, physics, fluidics, and manufacturing to bring new products in the doctor’s and patient’s hands. He is now in charge of the development of novel electronic drug delivery devices for Merck.

    Sigrid Van Dyck

    Senior Director Technical Operations, Janssen Supply Chain, Johnson & Johnson
    Sigrid Van Dyck

    Sigrid Van Dyck is a Senior Director at Johnson & Johnson, located in Switzerland, where she leads the Technical Operations Parenteral Technology Platform. She is managing New Product introduction and Life Cycle Management of biological and other parenteral products, as well as providing technical support to the internal and external network.

    Sigrid joined J&J in 2006 as a Senior Scientist, supporting various New Product Introductions. Her professional career started with Schering-Plough Belgium, where she held positions in Quality and Sterile Manufacturing Operations. Sigrid holds a Ph.D. in Pharmaceutical Sciences.
     

    Stephen Paboojian

    Senior New Technology Project Leader II, Novartis Pharma AG
    Stephen Paboojian

    Stephen Paboojian is an engineer and senior project leader for the development of pharmaceutical delivery systems, from medical devices and primary drug packaging to instructional materials and custom outer packaging. Steve has a proven track record of over 25 years of driving novel inventions from concept to commercial launch, contributing to global products in development for treatment of Macular Degeneration, COPD, Cystic Fibrosis, Multiple Sclerosis, and Diabetes.

    Terry Reed

    Director Business Development, AstraZeneca
    Terry Reed

     

    Terry Reed is Director of Business Development in the Innovation Strategy & External Liaison group at AstraZeneca and has worked in the pharmaceutical industry for over 11 years. He has specific responsibility for the enhancement of AstraZeneca's Pharmaceutical Technology and Development capabilities, by enabling access to the best external science, technology and innovation. Terry has previous considerable experience in supporting Discovery opportunities with a specific focus on toxicological sciences. He’s been responsible for negotiating and executing over 200 transactions for a broad spectrum of activities spanning in-licensing/out-licensing of technology platforms and intellectual property as well as collaborations and consortiums with industry, biotech and academic partners.
    Prior to joining AstraZeneca Terry was Director of Commercial Development at Pharmagene. In all Terry has more than 25 years commercial experience in the life science sector, having also held business development and management positions at Oxford Gene Technology, De Novo Pharmaceuticals, Applied Biosystems, Amersham and Millipore.
     

    Tom Lawrie-Fussey

    Head of Digital Health, Cambridge Design Partnership
    Tom Lawrie-Fussey

    Tom Lawrie-Fussey is a digital services specialist at technology and product design firm Cambridge Design Partnership. He is a Chartered Engineer with a master’s degree and has more than 15 years’ product development experience. Tom works across multiple industry sectors, primarily focused on drug delivery, consumer health, and FMCG clients, where he drives various digital initiatives to help guide clients along their own digital roadmap. He specialises in digital implementation, linking device development with communications and data analytics platforms. Tom provides a technology-agnostic, pragmatic approach that is human-centred – unlocking benefits for all stakeholders and, ultimately, generating new revenue streams.

    Vasco Filipe

    Senior research scientist - Formulation Development, Sanofi
    Vasco Filipe

    Vasco Filipe

    Senior research scientist - Formulation Development, Sanofi
    Vasco Filipe

    Vasco Filipe is a Biological Engineer and obtained a Ph.D. degree in Pharmaceutical Sciences from the Utrecht University (The Netherlands) in 2011. His thesis focused on the physicochemical characteristics, stability in biological fluids and immunogenicity of monoclonal antibody aggregates. After a post-doc in 2012 on a similar topic, he then joined Adocia in 2013 (Lyon, France), where he worked as the Project Leader for all monoclonal antibodies collaborations. In 2015 he joined Sanofi (Paris, France), where he now works as a Section Head of Formulation and Process Development in the department of Biologics Drug Product Development.

    Sponsors and Exhibitors

    Supporters

    Workshops

    Use-related Risk Analysis throughout a Design and Development Project
    Workshop

    Use-related Risk Analysis throughout a Design and Development Project

    Copthorne Tara Hotel
    14th May 2019
    London, United Kingdom

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Speaker line-up

    Download

    Past Attendees 2018

    Download

    Conference Programme 2019

    Download

    Presentation by Uri Baruch, Cambridge Design Partnership

    Download

    Presentation by Pierre Goldbach, Roche

    Download

    Presentation by Michhael Hooven, Enable Injections

    Download

    Presentation by Jayne Lawrence, The University of Manchester

    Download

    Presentation by Francesco Malavasi, Novartis

    Download

    Presentation by Fie Falck Larsen, Leo

    Download

    Presentation by Cedric Gysel, Johnson & Johnson

    Download

    Presentation by Andrew Fiorini, GSK

    Download

    Presentation by Dr. Ahmed Youssef, Sanofi

    Download

    Sponsors and Exhibitors


    Almac

    Sponsors and Exhibitors
    http://www.almacgroup.com

    Almac is an established CDMO organization that provides an extensive range of integrated services to the global biopharma industry. Almac provides specialised packaging solutions for all biopharmaceutical dosage forms (vials, ampoules, pre-filled syringes, auto-injector pens) and can support all your packaging needs from niche/orphan drug launches to high volume products.


    Crux Product Design Ltd

    Sponsors and Exhibitors
    http://www.cruxproductdesign.com/

    Crux is a product development consultancy serving the pharmaceutical industry with a fully integrated service wrapped around solid technical knowledge. Our highly experienced team consists of industrial designers, mechanical engineers, electronics & software engineers and simulation experts. We’re trusted by our clients to solve their most technically challenging briefs.


    EVEON

    Sponsors and Exhibitors
    http://www.eveon.eu

    Transforming patient experience. EVEON is the partner of pharmaceutical, biotech companies and medical device manufacturers for the development of automatic, safe and connected devices. The company facilitates and controls the handling, preparation and administration of molecules. Our innovative solutions meet specific requirements of a wide range of applications.

    Media Partners


    World Pharma News

    Supporters
    http://www.worldpharmanews.com/



    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    ONdrugDelivery Magazine

    Supporters
    http://ondrugdelivery.com

    ONdrugDelivery Magazine is the highly regarded, world-leading series of sponsored themed drug delivery publications. Uniquely, each issue focuses tightly on one topic within the field of drug delivery. With a truly global readership already in excess of 40,000, and with contributions and loyal support from many of the most important companies in the drug delivery business - from among the largest to the smallest - ONdrugDelivery Magazine is a must for those in the industry who need to know what's going on in drug delivery.


    pharmanews hq

    Supporters
    http://http://pharmanewshq.com

    MedChemNet provides a unique and unparalleled platform for the medicinal chemistry community to share insights, discuss the latest research, and help move the field forward. MedChemNet covers all aspects of the drug discovery pipeline, from target identification and validation, through computer aided drug design (CADD), synthesis, screening and other biophysical techniques, to development of novel lead compounds and pre-clinical in vivo proof of concept. We also cover the design of synthetic drug delivery carriers and ADME/toxicology studies, as well as intellectual property and economic related issues. Website: Welcome to Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out